4-ethoxy-N-{2-[(6-phenylpyridazin-3-yl)oxy]ethyl}benzamide结构式
|
常用名 | 4-ethoxy-N-{2-[(6-phenylpyridazin-3-yl)oxy]ethyl}benzamide | 英文名 | 4-ethoxy-N-{2-[(6-phenylpyridazin-3-yl)oxy]ethyl}benzamide |
|---|---|---|---|---|
| CAS号 | 920180-63-8 | 分子量 | 363.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H21N3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 4-ethoxy-N-{2-[(6-phenylpyridazin-3-yl)oxy]ethyl}benzamide |
|---|
| 分子式 | C21H21N3O3 |
|---|---|
| 分子量 | 363.4 |
| InChIKey | FRQLWYZOOYGKDK-UHFFFAOYSA-N |
| SMILES | CCOC1=CC=C(C=C1)C(=O)NCCOC2=NN=C(C=C2)C3=CC=CC=C3 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|